Technical Absorbents

Free membership

Receive our weekly Newsletter
and set tailored daily news alerts.

Technology/Machinery

US BioDesign relocates as it plans expansion

US BioDesign, a leader in the production of biomedical textile structure components, has announced the relocation of its current manufacturing headquarters in Perkasie, PA, to a business campus in Quakertown, as it plans its future growth. According to US BioDesign President and Founder Tom Molz, the company's relocation supports essential, short-term business goals and is key to advancing longer-term growth strategies. "This is an exciting time for US BioDesign. With multiple developmental projects nearing commercialisation, this is the right time for us to expand. Our business is growing rapidly and we've got a lot of momentum moving forward. We're excited about the future," he said.

25th July 2013

Innovation in Textiles
 |  Quakertown, PA

Medical/Hygiene

US BioDesign, a leader in the production of biomedical textile structure components, has announced the relocation of its current manufacturing headquarters in Perkasie, PA, to a business campus in Quakertown, as it plans its future growth.

According to US BioDesign President and Founder Tom Molz, the company's relocation supports essential, short-term business goals and is key to advancing longer-term growth strategies.

"This is an exciting time for US BioDesign. With multiple developmental projects nearing commercialisation, this is the right time for us to expand.  Our business is growing rapidly and we've got a lot of momentum moving forward. We're excited about the future," he said.

At its new location, the company will develop and manufacture biomedical textile components for medical device manufacturers. The new facility is said to encompass clean room technology, state-of-the-art manufacturing equipment, increased capacity, and dedicated developmental support, in addition to expanded office space.

Industry growth

Comprised of surgical, cardiovascular, neurovascular, neurological, orthopedic, general medical and other devices, the global medical device industry has experienced significant growth over the last five years and is expected to continue. According to US BioDesign, neurology devices are predicted to post the fastest growth, expected to expand by 6.1% per year.

"Our decision to relocate was made in response to listening to our customers and our evaluation of where we see the industry moving, based on current and emerging industry trends. This move gives us the technological bandwidth and expanded manufacturing capabilities and capacity that we need to respond with agility and flexibility as the needs of our customers evolve," commented Molz.

US BioDesign

US BioDesign founder Tom Molz has driven discovery and innovation within the medical/biomedical textiles and implantable fabrics for medical devices industry for more than 20 years, and has been involved with biomedical textile developments in different areas of the medical device industry.

US BioDesign is the second biomedical manufacturing company founded by Molz. It draws upon deep biomedical engineering expertise and an unparalleled understanding of medical device construct development involving polymeric and/or metallic raw materials to deliver efficient engineering solutions and commercial development support.

www.usbiodesign.com

 

Latest Reports

Business intelligence for the fibre, textiles and apparel industries: technologies, innovations, markets, investments, trade policy, sourcing, strategy...

Find out more